The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial

Abstract Objective Guidelines exist for the use of low-dose aspirin in the general population for primary cardiovascular (CV) prevention, but the risk-benefit considerations may differ in RA. While RA confers an increased CV risk, such patients more likely use NSAIDs and corticosteroids. Methods We...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology (Oxford, England) England), 2018-08, Vol.57 (8), p.1364-1369
Hauptverfasser:	Solomon, Daniel H, Libby, Peter, Yeomans, Neville D, Wang, Qiuqing, Wolski, Kathy E, Nissen, Steven E, Husni, M Elaine
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspirin Celecoxib Corticosteroids Drug dosages Health risk assessment Ibuprofen Naproxen Nonsteroidal anti-inflammatory drugs Omeprazole Rheumatoid arthritis Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!